A Randomized, Open‐Label, Phase I Clinical Study of Dalpiciclib With Different Specifications After Process Modification in Healthy Chinese Volunteers. - Tao, Ye; Li, Ting; Lin, Pingping; Jiang, Xin; Shi, Ping; Fu, Yao; Liu, Xin; Wang, Chenjing; Li, Shaorong; Li, Xiaofeng; Cao, Yu (Clinical Pharmacology in Drug Development, 2023)